Mihai, N.; Olariu, M.C.; Ganea, O.-A.; Adamescu, A.-I.; Molagic, V.; Aramă, Ș.S.; Tilișcan, C.; Aramă, V.
Risk of Hepatitis B Virus Reactivation in COVID-19 Patients Receiving Immunosuppressive Treatment: A Prospective Study. J. Clin. Med. 2024, 13, 6032.
https://doi.org/10.3390/jcm13206032
AMA Style
Mihai N, Olariu MC, Ganea O-A, Adamescu A-I, Molagic V, Aramă ȘS, Tilișcan C, Aramă V.
Risk of Hepatitis B Virus Reactivation in COVID-19 Patients Receiving Immunosuppressive Treatment: A Prospective Study. Journal of Clinical Medicine. 2024; 13(20):6032.
https://doi.org/10.3390/jcm13206032
Chicago/Turabian Style
Mihai, Nicoleta, Mihaela Cristina Olariu, Oana-Alexandra Ganea, Aida-Isabela Adamescu, Violeta Molagic, Ștefan Sorin Aramă, Cătălin Tilișcan, and Victoria Aramă.
2024. "Risk of Hepatitis B Virus Reactivation in COVID-19 Patients Receiving Immunosuppressive Treatment: A Prospective Study" Journal of Clinical Medicine 13, no. 20: 6032.
https://doi.org/10.3390/jcm13206032
APA Style
Mihai, N., Olariu, M. C., Ganea, O.-A., Adamescu, A.-I., Molagic, V., Aramă, Ș. S., Tilișcan, C., & Aramă, V.
(2024). Risk of Hepatitis B Virus Reactivation in COVID-19 Patients Receiving Immunosuppressive Treatment: A Prospective Study. Journal of Clinical Medicine, 13(20), 6032.
https://doi.org/10.3390/jcm13206032
